Serum Amyloid A and Lipoprotein Associated Phospholipase A(2) Levels in Patients with Malign Melanoma: Correlations with Clinical Assessment and Stage
Articles > Article · 2018
Authors: YAVUZ KAYAŞ, Ferhan GİRGİN SAĞIN, Yasemin AKÇAY, Gizem Kocabas Yenipazar, Elif AZARSIZ, Eser YILDIRIM SÖZMEN, FEZAL ÖZDEMİR, Işıl TUNA
TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, Journal Indexed in SCI Expanded, International, 2018, vol 12, pp 135-142
DOI: 10.4274/tdd.3643
Summary
Objective: The lack of validated, sensitive, and specific biomarkers for early diagnosis and follow-up of patients with malign melanoma (MM) is a major problem today. In this study, we aimed to investigate the correlations of two inflammatory biomarkers-serum amyloid A (SAA) and lipoprotein associated phospholipase A 2 (Lp-PLA(2))-in clinical follow-up and staging of MM.